Hypogonadism News and Research

RSS

Testicular failure, also known as primary hypogonadism, is an uncommon condition that is characterized by the inability of the testicles to produce sperm and the male hormone testosterone. The are many factors that have been postulated as causes of the condition, which give rise to a wide array of signs and symptoms. These factors can sometimes make diagnosis as well as treatment of testicular failure a challenging problem.

Obesity strikes below the belt: Study reveals link between obesity and male infertility

The influence of obesity on male fertility is still under debate. In the present investigation, researchers scrutinized semen samples from both obese individuals and those of normal weight. The aim was to explore the relationship between obesity, the length of sperm telomeres, levels of mRNA associated with autophagy, and diverse semen characteristics.

29 May 2023

ANDRONET COST Action aims to improve research, education, and public awareness in andrology

Raising awareness of male health: ANDRONET COST Action to improve research, education, and public awareness in the field of andrology.

13 Mar 2023

The impact of viral infections on the human endocrine system

Researchers briefly outlined how viral infections trigger endocrinopathies in humans.

3 Feb 2023

Insulin-like peptide 3 may be a predictor of hypogonadism and age-associated morbidity in older males

Researchers evaluated whether insulin-like peptide 3 (INSL3) could predict hypogonadism and age-associated morbidity in older males.

3 Jan 2023

Study opens avenues to improve prognosis of children with congenital hypogonadotropic hypogonadism

Congenital hypogonadotropic hypogonadism is a rare disease characterized by delayed puberty or the complete absence of puberty in adolescence, leading to infertility.

5 Oct 2022

Clinical practice recommendations provide evidence-based clinical guidelines on the management of erectile dysfunction in Australia

New clinical guidelines from the USANZ and the AChSHM for the RACP could help manage erectile dysfunction better "amid saturation advertising of online men's health platforms."

20 Sep 2022

Is male hypogonadism a risk factor for hospitalization for COVID-19?

Researchers found an association between male hypogonadism and hospitalization risk for COVID-19.

7 Sep 2022

Male hypogonadism associated with risk of hospitalization for COVID-19

Men with low testosterone levels are more likely to require hospitalization after COVID-19 infection than men with normal levels or those on testosterone therapy, according to Saint Louis University School of Medicine and Washington University School of Medicine in St. Louis researchers.

2 Sep 2022

Men with low testosterone may have higher risk of COVID-19 hospitalization

Men with low testosterone who develop COVID-19 are at elevated risk of becoming seriously ill and ending up in the hospital, according to a study by researchers at Washington University School of Medicine in St. Louis and Saint Louis University School of Medicine.

2 Sep 2022

What is the impact of COVID-19 on male reproductive health?

In a recent study, researchers assessed male reproductive health three months after COVID-19 infection.

12 Aug 2022

How does COVID-19 affect sexual and bladder functions in men?

Researchers discuss the impact of COVID-19 on the urogenital health of males.

1 Aug 2022

Study investigates the combined effects of aging and HIV-1 Tat expression in mice

A new research paper was published in Aging ("Aging (Albany NY)" by Medline/PubMed, "Aging-US" by Web of Science) Volume 14, Issue 13, entitled, "Age-related neuroendocrine, cognitive, and behavioral co-morbidities are promoted by HIV-1 Tat expression in male mice."

29 Jul 2022

Analysis finds little proof that testosterone treatment increases the risk of cardiovascular events

Testosterone replacement therapy appears safe in the short-to-medium term to treat a condition caused by deficiency of the male sex hormone, according to the most comprehensive analysis of the treatment to date, published in The Lancet Healthy Longevity journal.

9 Jun 2022

Hypogonadism News and Research

Further Reading

Obesity strikes below the belt: Study reveals link between obesity and male infertility

ANDRONET COST Action aims to improve research, education, and public awareness in andrology

The impact of viral infections on the human endocrine system

Insulin-like peptide 3 may be a predictor of hypogonadism and age-associated morbidity in older males

Study opens avenues to improve prognosis of children with congenital hypogonadotropic hypogonadism

Clinical practice recommendations provide evidence-based clinical guidelines on the management of erectile dysfunction in Australia

Is male hypogonadism a risk factor for hospitalization for COVID-19?

Male hypogonadism associated with risk of hospitalization for COVID-19

Men with low testosterone may have higher risk of COVID-19 hospitalization

What is the impact of COVID-19 on male reproductive health?

How does COVID-19 affect sexual and bladder functions in men?

Study investigates the combined effects of aging and HIV-1 Tat expression in mice

Analysis finds little proof that testosterone treatment increases the risk of cardiovascular events

How SARS-CoV-2 affects the male reproductive system

Impact of SARS-CoV-2 infection on testis function

Can COVID-19 affect erectile function?

Hypopituitarism and COVID-19 – exploring a possible bidirectional relationship?

Does SARS-CoV-2 affect male fertility?

Study: Low fat diets reduce men’s testosterone levels

COVID-19 may deteriorate men's testosterone levels, new data suggests

Exploring the intersection of biology and proteomics

Unlocking the Secrets of Multiple Sclerosis Progression: Brain-Immune Cell Communication

Passing on Polycystic Ovary Syndrome: Health risks for male offspring of women with PCOS

Latest News